WallStreetZenWallStreetZen

NASDAQ: SILO
Silo Pharma Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

SILO past revenue growth

How has SILO's revenue growth performed historically?
Company
0%
Industry
148.64%
Market
17.33%
SILO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SILO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

SILO earnings and revenue history

Current Revenue
$72.1k
Current Earnings
-$3.7M
Current Profit Margin
-5,132.6%

SILO Return on Equity

Current Company
-47.1%
Current Industry
-63.5%
Current Market
188%
SILO's Return on Equity (-47.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SILO announces earnings.

SILO Return on Assets

Current Company
-39%
Current Industry
2.9%
SILO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SILO Return on Capital Employed

Current Company
-53.02%
Current Industry
19.5%
SILO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SILO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SILO$72.10k-$3.70M-$3.70M+15.46%N/A
TCBP$0.00-$8.05M-$7.57M-100.00%N/A
PALI$250.00k-$12.20M-$12.32M-0.78%N/A
GTBP$0.00-$7.38M-$7.60MN/AN/A
ALZN$0.00-$12.35M-$12.40MN/AN/A
View Top Biotech Stocks

Silo Pharma Earnings & Revenue FAQ

What were SILO's earnings last quarter?

On Invalid Date, Silo Pharma (NASDAQ: SILO) reported Q4 2023 earnings per share (EPS) of -$0.38, up 34.48% year over year. Total Silo Pharma earnings for the quarter were -$1.12 million. In the same quarter last year, Silo Pharma's earnings per share (EPS) was -$0.58.

If you're new to stock investing, here's how to buy Silo Pharma stock.

What was SILO's earnings growth in the past year?

As of Q2 2024, Silo Pharma's earnings has grown year over year. Silo Pharma's earnings in the past year totalled -$3.70 million.

What was SILO's revenue last quarter?

On Invalid Date, Silo Pharma (NASDAQ: SILO) reported Q4 2023 revenue of $18.03 thousand up 0% year over year. In the same quarter last year, Silo Pharma's revenue was $18.03 thousand.

What was SILO's revenue growth in the past year?

As of Q2 2024, Silo Pharma's revenue has grown 0% year over year. This is 148.64 percentage points lower than the US Biotechnology industry revenue growth rate of 148.64%. Silo Pharma's revenue in the past year totalled $72.10 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.